$750M
Reported book value
| # | Security | Shares | Share Δ QoQ | Value | % of book |
|---|---|---|---|---|---|
| 1 | NAMS Newamsterdam Pharma Company | 8.5M | −7.7% | $288M | 38.3% |
| 2 | MPLT Maplight Therapeutics Inc | 3.2M | +0.0% | $116M | 15.4% |
| 3 | DYN Dyne Therapeutics Inc | 3.8M | −17.1% | $85M | 11.4% |
| 4 | VOR Vor Biopharma Inc | 4.1M | +0.0% | $76M | 10.1% |
| 5 | DMRA Damora Therapeutics Inc | 2.4M | +0.0% | $63M | 8.5% |
| 6 | REPL Replimune Group Inc | 2.8M | +0.0% | $31M | 4.1% |
| 7 | CBIO Crescent Biopharma Inc. | 1.7M | +0.0% | $30M | 4.0% |
| 8 | AURA Aura Biosciences Inc | 4.1M | — | $29M | 3.8% |
| 9 | ENGENE HOLDINGS INC Engene Holdings Inc | 9.6M | +0.0% | $17M | 2.2% |
| 10 | BCYC Bicycle Therapeutics Plc | 3.5M | +0.0% | $15M | 2.0% |
| 11 | ENGENE HOLDINGS INC Engene Holdings Inc | 2.9M | +0.0% | $834,376 | 0.1% |